These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23173794)

  • 1. Tissue bioanalysis of biotherapeutics and drug targets to support PK/PD.
    Neubert H; Fountain S; King L; Clark T; Weng Y; O'Hara DM; Li W; Leung S; Ray C; Palandra J; Ocaña MF; Chen J; Ji C; Wang M; Long K; Gorovits B; Fluhler E
    Bioanalysis; 2012 Nov; 4(21):2589-604. PubMed ID: 23173794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioanalysis of target biomarker and PK/PD relevancy during the development of biotherapeutics.
    Lee JW; Salimi-Moosavi H
    Bioanalysis; 2012 Oct; 4(20):2513-23. PubMed ID: 23157359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotherapeutic bioanalysis: a multi-indication case study review.
    Myler HA; Given A; Kolz K; Mora JR; Hristopoulos G
    Bioanalysis; 2011 Mar; 3(6):623-43. PubMed ID: 21417732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioanalytical considerations in the comparability assessment of biotherapeutics.
    Lee JW; Wang YM; Moxness M; DeSilva B
    Bioanalysis; 2011 Mar; 3(6):613-22. PubMed ID: 21417731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics.
    Lee JW
    Bioanalysis; 2009 Nov; 1(8):1461-74. PubMed ID: 21083095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How the bioanalytical scientist plays a key role in interdisciplinary project teams in the development of biotherapeutics - a reflection of the European Bioanalysis Forum.
    Dudal S; Staack RF; Stoellner D; Fjording MS; Vieser E; Pascual MH; Brudny-Kloeppel M; Golob M
    Bioanalysis; 2014 May; 6(10):1339-48. PubMed ID: 24958118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug bioanalysis and biomarker discovery at the Commissariat à l'énergie atomique et aux énergies alternatives.
    Ezan E; Becher F; Benech H; Fenaille F; Junot C; Mabondzo A; Pruvost A
    Bioanalysis; 2010 Apr; 2(4):713-7. PubMed ID: 21083268
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations on ISR in multi analyte assays, QA/bioanalytical consultants and GCP by Global CRO Council for Bioanalysis (GCC).
    Sangster T; Maltas J; Struwe P; Hillier J; Boterman M; Doig M; Breda M; Garofolo F; Caturla MC; Couerbe P; Schiebl C; Pattison C; Goodwin L; Segers R; Garofolo W; Folguera L; Zimmer D; Zimmerman T; Pawula M; Tang D; Cox C; Bigogno C; Schoutsen D; de Boer T; Green R; Houghton R; Sable R; Siethoff C; Harter T; Best S;
    Bioanalysis; 2012 Jul; 4(14):1723-30. PubMed ID: 22877218
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysis.
    Wang YM; Jawa V; Ma M
    Bioanalysis; 2014 Jan; 6(1):79-87. PubMed ID: 24341496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.
    Danhof M; de Lange EC; Della Pasqua OE; Ploeger BA; Voskuyl RA
    Trends Pharmacol Sci; 2008 Apr; 29(4):186-91. PubMed ID: 18353445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On setting the first dose in man: quantitating biotherapeutic drug-target binding through pharmacokinetic and pharmacodynamic models.
    Lowe PJ; Tannenbaum S; Wu K; Lloyd P; Sims J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):195-209. PubMed ID: 20050847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PK-PD modeling of protein drugs: implications in assay development.
    Roskos LK; Schneider A; Vainshtein I; Schwickart M; Lee R; Lu H; Faggioni R; Liang M
    Bioanalysis; 2011 Mar; 3(6):659-75. PubMed ID: 21417734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capillary electrophoresis-mass spectrometry, an attractive tool for drug bioanalysis and biomarker discovery.
    Servais AC; Crommen J; Fillet M
    Electrophoresis; 2006 Jul; 27(13):2616-29. PubMed ID: 16817163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling.
    Colburn WA; Lee JW
    Clin Pharmacokinet; 2003; 42(12):997-1022. PubMed ID: 12959633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status and future perspective on preclinical pharmacokinetic and pharmacodynamic (PK/PD) analysis: Survey in Japan pharmaceutical manufacturers association (JPMA).
    Goto A; Abe S; Koshiba S; Yamaguchi K; Sato N; Kurahashi Y
    Drug Metab Pharmacokinet; 2019 Apr; 34(2):148-154. PubMed ID: 30827921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inductively coupled plasma-MS in drug development: bioanalytical aspects and applications.
    van Heuveln F; Meijering H; Wieling J
    Bioanalysis; 2012 Aug; 4(15):1933-65. PubMed ID: 22943623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies.
    Muller PY; Milton M; Lloyd P; Sims J; Brennan FR
    Curr Opin Biotechnol; 2009 Dec; 20(6):722-9. PubMed ID: 19896825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to calibration curves in bioanalysis.
    Brewer E; Bollin E
    Bioanalysis; 2009 Oct; 1(7):1201-8. PubMed ID: 21083046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance.
    Savoie N; Garofolo F; van Amsterdam P; Bansal S; Beaver C; Bedford P; Booth BP; Evans C; Jemal M; Lefebvre M; Lopes de Silva AL; Lowes S; Marini JC; Massé R; Mawer L; Ormsby E; Rocci ML; Viswanathan C; Wakelin-Smith J; Welink J; White JT; Woolf E
    Bioanalysis; 2010 Dec; 2(12):1945-60. PubMed ID: 21110739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key elements of bioanalytical method validation for small molecules.
    Bansal S; DeStefano A
    AAPS J; 2007 Mar; 9(1):E109-14. PubMed ID: 17408234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.